Department of Chemistry & Biochemistry,
Harper Cancer Research Institute,
Department of Chemistry & Biochemistry, Harper Cancer Research Institute
M. Sharon Stack has not added Biography.
If you are M. Sharon Stack and would like to personalize this page please email our Author Liaison for assistance.
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.
Cancer treatment and research , 2002 | Pubmed ID: 11775454
Ovarian cancer-associated proteinases.
Cancer treatment and research , 2002 | Pubmed ID: 11775460
Tumor production of angiostatin is enhanced after exposure to TNF-alpha.
International journal of cancer Feb, 2002 | Pubmed ID: 11802200
The mechanism of action of angiostatin: can you teach an old dog new tricks?
Thrombosis and haemostasis Mar, 2002 | Pubmed ID: 11916069
Analysis of matrix degradation.
Methods in cell biology , 2002 | Pubmed ID: 12070993
Proteinase suppression by E-cadherin-mediated cell-cell attachment in premalignant oral keratinocytes.
The Journal of biological chemistry Oct, 2002 | Pubmed ID: 12138162
Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
The Journal of biological chemistry Oct, 2002 | Pubmed ID: 12145314
Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells.
The Journal of biological chemistry Nov, 2002 | Pubmed ID: 12194986
Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma.
Cancer Dec, 2002 | Pubmed ID: 12467066
Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.
The Journal of biological chemistry May, 2003 | Pubmed ID: 12642591
Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase.
The Journal of biological chemistry Feb, 2004 | Pubmed ID: 14670950
Proteases, extracellular matrix, and cancer: a workshop of the path B study section.
The American journal of pathology Apr, 2004 | Pubmed ID: 15039201
Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates.
Proceedings of the National Academy of Sciences of the United States of America May, 2004 | Pubmed ID: 15118097
Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma.
The Journal of biological chemistry Aug, 2004 | Pubmed ID: 15180997
Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells.
The Journal of biological chemistry Aug, 2004 | Pubmed ID: 15205458
Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis.
The Journal of biological chemistry Sep, 2004 | Pubmed ID: 15247230
Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.
Cancer research Oct, 2004 | Pubmed ID: 15466198
Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
Cancer research Mar, 2005 | Pubmed ID: 15781636
Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation.
Cancer research Oct, 2005 | Pubmed ID: 16230389
Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways.
The Journal of biological chemistry May, 2006 | Pubmed ID: 16510444
Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.
Molecular carcinogenesis Nov, 2006 | Pubmed ID: 16788982
Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression.
The Journal of biological chemistry Feb, 2007 | Pubmed ID: 17158885
Pushing the limit: masticatory stress and adaptive plasticity in mammalian craniomandibular joints.
The Journal of experimental biology Feb, 2007 | Pubmed ID: 17267649
Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
Molecular cancer research : MCR Feb, 2007 | Pubmed ID: 17314270
Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
Cancer research Mar, 2007 | Pubmed ID: 17332331
Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion.
Nature cell biology Aug, 2007 | Pubmed ID: 17618273
Activation-coupled membrane-type 1 matrix metalloproteinase membrane trafficking.
The Biochemical journal Oct, 2007 | Pubmed ID: 17650075
Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis.
Seminars in cell & developmental biology Feb, 2008 | Pubmed ID: 17702616
Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity.
The Biochemical journal Oct, 2007 | Pubmed ID: 17880283
Synthesis and anticancer activities of 6-amino amonafide derivatives.
Anti-cancer drugs Jan, 2008 | Pubmed ID: 18043127
Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.
Cancer Apr, 2008 | Pubmed ID: 18260155
Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma.
Laboratory investigation; a journal of technical methods and pathology Jun, 2008 | Pubmed ID: 18362906
Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression.
Clinical & experimental metastasis , 2008 | Pubmed ID: 18398687
Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner.
The Journal of biological chemistry Jul, 2008 | Pubmed ID: 18499661
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
Cancer research Jun, 2008 | Pubmed ID: 18559505
SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells.
Gynecologic oncology Oct, 2008 | Pubmed ID: 18678400
Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma.
Gynecologic oncology Feb, 2009 | Pubmed ID: 18976802
Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity.
Histology and histopathology Feb, 2009 | Pubmed ID: 19085836
EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.
Future oncology (London, England) Apr, 2009 | Pubmed ID: 19374540
Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion.
International journal of cancer. Journal international du cancer Aug, 2009 | Pubmed ID: 19382180
Modulation of the membrane type 1 matrix metalloproteinase cytoplasmic tail enhances tumor cell invasion and proliferation in three-dimensional collagen matrices.
The Journal of biological chemistry Jul, 2009 | Pubmed ID: 19458085
Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen.
Molecular cancer research : MCR Jun, 2009 | Pubmed ID: 19509114
Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.
Cancer research Sep, 2009 | Pubmed ID: 19706774
Activated epidermal growth factor receptor in ovarian cancer.
Cancer treatment and research , 2009 | Pubmed ID: 19763438
Microenvironmental regulation of ovarian cancer metastasis.
Cancer treatment and research , 2009 | Pubmed ID: 19763443
Targeting the EGF receptor for ovarian cancer therapy.
Journal of oncology , 2010 | Pubmed ID: 20066160
Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.
Molecular cancer research : MCR Feb, 2010 | Pubmed ID: 20145038
Masticatory loading, function, and plasticity: a microanatomical analysis of mammalian circumorbital soft-tissue structures.
Anatomical record (Hoboken, N.J. : 2007) Apr, 2010 | Pubmed ID: 20235321
Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma.
Molecular cancer research : MCR May, 2010 | Pubmed ID: 20460402
Molecules of cell adhesion and extracellular matrix proteolysis in oral squamous cell carcinoma.
Histology and histopathology Jul, 2010 | Pubmed ID: 20503180
Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts.
Archives of oral biology May, 2011 | Pubmed ID: 21146154
Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma.
The Journal of biological chemistry Mar, 2011 | Pubmed ID: 21163944
Integrin regulation of beta-catenin signaling in ovarian carcinoma.
The Journal of biological chemistry Jul, 2011 | Pubmed ID: 21518759
Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas.
Molecular and cellular biochemistry Nov, 2011 | Pubmed ID: 21630091
Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.
The Biochemical journal Jul, 2011 | Pubmed ID: 21668411
Using "Mighty Mouse" to understand masticatory plasticity: myostatin-deficient mice and musculoskeletal function.
Integrative and comparative biology Sep, 2008 | Pubmed ID: 21669797
Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cells.
American journal of obstetrics and gynecology Mar, 2012 | Pubmed ID: 22206747
The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.
The Journal of biological chemistry Mar, 2012 | Pubmed ID: 22315226
Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma.
The Biochemical journal Apr, 2012 | Pubmed ID: 22452816
Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells.
Journal of oncology , 2012 | Pubmed ID: 22593767
Fluorescence In Situ Hybridization for MicroRNA Detection in Archived Oral Cancer Tissues.
Journal of oncology , 2012 | Pubmed ID: 22654907
Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein.
The Journal of biological chemistry Jan, 2013 | Pubmed ID: 23152495
Detecting microRNA in human cancer tissues with fluorescence in situ hybridization.
Methods in molecular biology (Clifton, N.J.) , 2013 | Pubmed ID: 24026683
Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma.
Oral oncology May, 2014 | Pubmed ID: 24582884
An ion-exchange nanomembrane sensor for detection of nucleic acids using a surface charge inversion phenomenon.
Biosensors & bioelectronics Oct, 2014 | Pubmed ID: 24787123
Membrane-type I matrix metalloproteinase-dependent ectodomain shedding of mucin16/ CA-125 on ovarian cancer cells modulates adhesion and invasion of peritoneal mesothelium.
Biological chemistry Oct, 2014 | Pubmed ID: 25205731
Correlation of X-ray computed tomography with quantitative nuclear magnetic resonance methods for pre-clinical measurement of adipose and lean tissues in living mice.
Sensors (Basel, Switzerland) , 2014 | Pubmed ID: 25299952
Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.
The American journal of pathology Mar, 2015 | Pubmed ID: 25572154
Decrease of miR-146a is associated with the aggressiveness of human oral squamous cell carcinoma.
Archives of oral biology Sep, 2015 | Pubmed ID: 26159827
Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
The Journal of biological chemistry Sep, 2015 | Pubmed ID: 26175151
Integrated, DC voltage-driven nucleic acid diagnostic platform for real sample analysis: Detection of oral cancer.
Talanta Dec, 2015 | Pubmed ID: 26459441
Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages.
Cancer research Dec, 2015 | Pubmed ID: 26573796
Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.
The Journal of biological chemistry Mar, 2016 | Pubmed ID: 26839311
Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells.
Oncotarget Mar, 2016 | Pubmed ID: 26959113
Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration.
BMC cancer , 2016 | Pubmed ID: 26964534